Gut bacteria therapy takes on superbugs in new trial

NCT ID NCT06321536

Recruiting now Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving a special mix of gut bacteria (microbiota therapy) can safely reduce the amount of drug-resistant germs living in the gut. About 60 adults who carry these superbugs will either receive the treatment or be observed. The goal is to see if the therapy can clear the resistant bacteria without causing serious side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTI-DRUG RESISTANT ORGANISM COLONIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTI-DRUG RESISTANT ORGANISM COLONIZATION

Contacts and locations

Locations

A.G Rhodes Wesley Woods
RECRUITING

Atlanta, Georgia, 30329, United States
Emory Long Term Acute Care (LTAC)
RECRUITING

Decatur, Georgia, 30030, United States
Penn Medicine Rittenhouse
RECRUITING

Philadelphia, Pennsylvania, 19146, United States
RML Specialty Hospital
RECRUITING

Hinsdale, Illinois, 60521, United States